Our leadership
Learn more
Milan combines over 20 years of transactional experience with the commercial insight gained from approximately eight years spent in-house in the life sciences and venture capital sectors.
Experience
Representative matters
Representative matters
RadNet, Inc. (Nasdaq: RDNT) and its AI-powered digital health division, DeepHealth, Inc. on their €230 million (including €15 million in milestones) acquisition of Gleamer SAS, a Paris-based medtech company and European leader in AI-powered medical imaging. The transaction positions DeepHealth as the largest provider of radiology clinical AI solutions and services in the world.
DeepHealth, Inc. on its acquisition of See-Mode Technologies, a medtech innovator based in Singapore and Australia specialising in AI for ultrasound imaging, with commercially available AI tools for thyroid and breast ultrasound.
Novartis on its acquisition of English biotech Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company focused on ophthalmology indications, for up to $1.5 billion (including $700 million due upon the achievement of certain milestones).
Mergers & Acquisitions
RadNet, Inc. (Nasdaq: RDNT) and its AI-powered digital health division, DeepHealth, Inc. on their €230 million (including €15 million in milestones) acquisition of Gleamer SAS, a Paris-based medtech company and European leader in AI-powered medical imaging. The transaction positions DeepHealth as the largest provider of radiology clinical AI solutions and services in the world.
DeepHealth, Inc. on its acquisition of See-Mode Technologies, a medtech innovator based in Singapore and Australia specialising in AI for ultrasound imaging, with commercially available AI tools for thyroid and breast ultrasound.
Novartis on its acquisition of English biotech Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company focused on ophthalmology indications, for up to $1.5 billion (including $700 million due upon the achievement of certain milestones).
ECM Partners and Metric Capital Partners on their auction process and sale of FAMAR to MidEuropa. FAMAR is a CDMO servicing the pharmaceutical industry through a network of six manufacturing sites located across Southern Europe and employing over 1,900 people.
Novartis on the divestment, for up to $210 million, of the U.S. rights to Proleukin (aldesleukin) to the Clinigen Group plc, including an associated purchase option agreement with Nestlé Health Science (the exclusive U.S. distributor of Proleukin via its subsidiary, Prometheus Laboratories).
DeepHealth, Inc. on its acquisition of the English venture capital-backed medtech company Kheiron Medical Technologies Limited, expanding DeepHealth’s AI-powered cancer diagnostics and screening capabilities.
A large multinational and publicly listed pharmaceutical company, headquartered in Europe, as they participated in an auction process (as one of two final bidders) seeking to acquire a portfolio of analgesic products valued at around €120 million from another large multinational pharmaceutical company.
The management of Actavis, one of the world’s leading generic pharmaceutical companies, in relation to the disposal of the Actavis Group to Watson Pharmaceuticals, Inc. for up to €4.5 billion.
RadNet, Inc. (Nasdaq: RDNT), a U.S. leader in the provision of outpatient diagnostic imaging services, on its acquisition of a 75% controlling interest in London-based Heart & Lung Imaging Limited, a teleradiology network focused on lung cancer screening.
AMR Action Fund, a mission-driven venture capital fund with approximately $1 billion under management and investing in biotechs developing traditional and innovative antimicrobials, on the sale of the English biotech Utility Therapeutics Limited to Alembic Pharmaceuticals, Inc.
Sandoz on its acquisition of GlaxoSmithKline Plc’s cephalosporin antibiotics business, comprising three established brands (Zinnat®, Zinacef®, and Fortum®), for up to $500 million.
A large European pharmaceutical company on a series of divestitures of rights to a variety of mature ophthalmology, oncology, and dermatology products, with deal values of between $15 million and $200 million across various geographies, and the associated licensing of intellectual property and provision of manufacturing and supply services.
A commercial-stage biotech headquartered and publicly listed in Europe as it sought to complete an approximately $600 million cross-border business combination with a U.S.-listed biotech.
Novartis on the acquisition of Ziarco Group Limited, a clinical-stage, private, venture capital-backed English company whose lead product, ZPL389, was a potential first-in-class oral treatment for moderate-to-severe eczema.
RadNet, Inc. (Nasdaq: RDNT) on its acquisition of CIMAR, a leading UK provider of cloud-native health care image management solutions across more than 50% of NHS trusts and 80% of UK private hospitals.
The shareholders and founders of the Digital Ventures Group, the developer and operator of an online classifieds platform allowing its users to post adverts for goods and services across a broad range of categories, with a presence in 15 countries and across five continents, on the sale of its holding company to a consortium of financial and strategic investors across Southern and Central Europe.
Corning Incorporated in relation to the English law aspects (transaction governed by New York law) of its acquisition of a majority of Becton, Dickinson and Company’s Discovery Labware unit for $730 million.
Novartis on its $355 million divestment to Alcon Inc. of the U.S. commercialisation rights to Simbrinza®, a fixed combination ophthalmic suspension indicated for the treatment of patients with open-angle glaucoma or ocular hypertension.
Novartis on its 2015 portfolio transformation, a three-part asset swap with GlaxoSmithKline Plc (GSK), and particularly the up to $7.1 billion (including milestones) sale of Novartis’ vaccines business to GSK.
Fairfax Financial Holdings Limited on its acquisition of Thomas Cook Group plc’s entire 77% stake in its Indian operations, Thomas Cook (India) Limited, for approximately £94 million.
General Electric on its $4.3 billion acquisition of the aviation business of Avio S.p.A., an Italy-based manufacturer of aviation propulsion components and systems for civil and military aircraft (then a Cinven portfolio company).
Liberty Global, Inc. on the English law aspects of its stock and cash merger with Virgin Media Inc., valued at approximately $23.3 billion.
Novartis on its $8.7 billion acquisition of AveXis Inc., a Nasdaq-listed clinical-stage gene therapy company whose subsequently approved lead product, AVXS-101 (now marketed as Zolgensma), is the first-ever one-time gene therapy for spinal muscular atrophy.
A special situations fund managed by one of the UK’s largest investment managers (with more than $10 billion of assets under management) on its various disposals of power and fuel barges to a range of international sellers and buyers (sale price of each power barge approximately $60 million).
Novartis on its acquisition of Spinifex Pharmaceuticals, Inc., a clinical-stage, private, venture capital-backed company whose lead product, EMA401, had established clinical proof of concept for the treatment of neuropathic pain.
A major Indian conglomerate on an auction sale of its business process outsourcing business.
Anglo American plc in relation to the English law aspects (transaction governed by New York law) of its sale of a 4.1% shareholding in Anglo American Sur S.A., a Chilean company, to Inversiones Mineras Becrux SpA, a Chilean joint venture of Codelco and Mitsui, for cash consideration of approximately $890 million.
SunGard Data Systems Inc. in relation to the English law aspects (transaction governed by New York law) of the sale of its Higher Education businesses to affiliates of Hellman & Friedman for an aggregate cash transaction purchase price of $1.78 billion.
Private Equity
Symphony Technology Group, a California-based private equity firm focused on investing in software, internet services, and technology-enabled business services, on its minority investments in (i) Graphnet Health Ltd, a major supplier of shared care record software for the NHS and the social care sector; and (ii) Shearwater Systems Ltd, responsible for the design, development, and deployment of the Rapport range of software products, providing mobile clinical applications and health records for the NHS, care professionals, and patients.
ECM Partners and Metric Capital Partners on their auction process and sale of FAMAR to MidEuropa. FAMAR is a CDMO servicing the pharmaceutical industry through a network of six manufacturing sites located across Southern Europe and employing over 1,900 people.
The China Investment Corporation on its co-investment of up to $100 million in Eaton Towers Holdings Limited, a London-based infrastructure sharing company providing passive network infrastructure and related services to mobile telecommunications operators in Africa.
Symphony Technology Group, a California-based private equity firm, on the English law aspects (transaction governed by New York law) of its acquisition of the scientific practices division of United BioSource Corporation.
Electra Private Equity (formerly managed by Epiris and then known as Electra Partners) on its secondary management buy-out investment in Hotter Shoes, the UK’s largest shoe manufacturer.
Qalaa Holdings (previously known as Citadel Capital SAE), a leading private equity firm in the Middle East and Africa, and the shareholders of its investment vehicle, Ambience Ventures Limited, on the acquisition of a controlling stake in Rift Valley Railways Investments (Pty) Ltd (RVR), the concession holding company in respect of the privatised railways in Kenya and Uganda. This mandate followed earlier advice to Primefuels (Kenya) and its founder management on their RVR contribution to, and management participation in, Ambience.
Francisco Partners, a leading technology-focused private equity firm based in San Francisco, in relation to the English law aspects (transaction governed by New York law) of its acquisition of the entire capital stock of Avangate Corporation N.V.
A private investor on the management buy-out of Searcys, a catering company operating restaurants and bars from a number of landmark locations around London.
Symphony Technology Group, a California-based private equity firm, on its acquisition of Jobrapido S.r.l., the job search engine division of the Daily Mail Group’s digital recruitment business (known as Evenbase).
Venture Capital
AMR Action Fund, a mission driven fund with c. $1billion under management and formed in collaboration with the World Health Organization, European Investment Bank, Wellcome Trust, GSK, Johnson & Johnson, Merck & Co., Novartis, Roche, Takeda and others, investing in biotechs developing traditional and innovative antimicrobials, on its investments in the English biotech, Utility Therapeutics Limited, in order to support the company’s efforts to bring pivmecillinam for the treatment of uncomplicated urinary tract infections (uUTIs) to the US market.
Hansa Biopharma AB on various strategic transactional and fundraising opportunities, including its 2024 directed share issue, raising gross proceeds of SEK 372 million ($34.6 million) from an international group of specialist life sciences investors.
AMR Action Fund on its investment in the English biotech, F2G Limited, as lead investor in the company’s £100 million series H1 fundraising.
AMR Action Fund on its investment in the French biotech, Antabio, as lead investor in the company’s €25 million series B fundraising.
Viacom on its minority equity investment in Zeebox Limited, whose business is based on the “zeebox” second screen application (available on laptops, iPhones, iPads, or Android smartphones), with Viacom joining an elite group of other investment and strategic partners in the media industry, including NBCUniversal, Comcast Cable, and BSkyB.
AMR Action Fund on its investment in the U.S. biotech Venatorx Pharmaceuticals, Inc. by way of convertible note.
MMA Insurance on its investment in Coverzones, a price comparison website for tailor-made business insurance products, in exchange for a minority stake among a group of high-profile private investors.
Eland Oil & Gas Limited on two rounds of fundraising by placement of 5% secured and unsecured convertible loan notes. The £105 million raised was used to fund a $154 million acquisition from Shell, Total, and ENI of a 45% participating interest in an onshore oil and gas block in Nigeria.
Restructuring and Reorganisations
A group of holders of lower tier 2 bonds issued by The Co-operative Bank plc in relation to the governance aspects of the bank’s recapitalisation plan, under which holders of the lower tier 2 bonds received a 70% equity stake, while The Co-operative Group retained a 30% equity stake.
Del Monte Foods Private Limited, an Indian processed food and beverage company, on the preservation of its rights in connection with the Chapter 11 proceedings in the United States of Del Monte Foods Corporation II Inc. and its affiliates and subsidiaries.
A trust services arm of a major investment bank on the reorganisation of the ownership structure of a South American family’s supermarket business, from direct local ownership into an offshore trust holding structure, thereby minimising the local expropriation risk (availing of a more favourable treatment afforded under international treaties).
St Martins, the UK-based real estate investment vehicle of the State of Kuwait, on its UK group restructuring and reorganisation.
Advised Bland Group Holdings, the parent company of the Griffon Hoverwork group, on the reorganisation of its UK group.
Joint Ventures
Novartis on its 2015 portfolio transformation, a three-part asset swap with GlaxoSmithKline Plc (GSK), and particularly the creation of a joint venture, with 2013 pro forma revenues of £6.5 billion, involving the combination of Novartis’ OTC business with GSK’s consumer health business.
Mediterranean Slate Limited on its joint venture with Best International for the purpose of investing in care homes, initially in the province of Granada, Spain.
Mediterranean Slate Limited and Best International, through their joint venture vehicle, Illandrefin BV, on a joint venture with Grupo Reifs, a Spanish operator of care homes, in relation to the development and operation of a care home concession in the municipality of Maracena, in the province of Granada, Spain.
Severfield Rowan plc, a structural steel group based in Yorkshire, UK, on a collaboration agreement with Zamil Steel Industries, one of the Middle East’s leading structural steelwork fabricators, to provide enhanced structural steelwork design, fabrication, and erection capability to clients across the Middle East and North Africa.
A Swiss-based private investor on his approximately $4.5 million majority joint venture investment in a Romanian business park.
One of France’s leading high-end nightclub brands on a joint venture, by way of a limited liability partnership, with a UK partner for the development of a nightclub in London’s West End.
Recognitions
Ranked as a Leading Partner in The Legal 500 UK for M&A: Lower Mid-Market Deals, £100m-£750m, 2026-2027
Ranked in Chambers UK for Corporate/M&A: £100-800 million, 2027
Ranked as a Notable Practitioner by IFLR1000 Global for United Kingdom Private Equity, 2025-2027
Credentials
Education
Education
- BPP Law School, 2004, LPC
- London School of Economics and Political Science, 2003, LL.B.
Professional admissions & qualifications
Professional admissions & qualifications
- England and Wales
News
1 / 7